Attached files
file | filename |
---|---|
EX-99.1 - EX-99.1 - BIO-PATH HOLDINGS INC | v191905_ex99-1.htm |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
8-K
CURRENT
REPORT PURSUANT
TO
SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date of
report (Date of earliest event reported): July 29, 2010
BIO-PATH
HOLDINGS, INC.
(Exact
name of registrant as specified in its charter)
Utah
|
000-53404
|
87-0652870
|
(State
or other jurisdiction
of
incorporation)
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
3293
Harrison Blvd., Ste. 220, Ogden, UT
|
84403
|
(Address
of principal executive offices)
|
(Zip
Code)
|
801-399-5500
(Registrant’s
Telephone Number, Including Area Code)
(Former
Name or Former Address, if Changed Since Last Report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General
Instruction A.2. below):
¨ Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
¨ Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
¨ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
¨ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
8.01 Other Events.
On July
29, 2010, Bio-Path Holdings, Inc. issued a press release titled “Bio-Path
Holdings Announces Dosing of First Patient in a Phase I Clinical Trial of Its
Liposomal Grb-2 Cancer Drug Candidate.” A copy of such press release
is attached hereto as Exhibit 99.1 and is incorporated herein by
reference.
Item
9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
|
Description | |
99.1
|
Press
Release dated July 29,
2010.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
BIO-PATH
HOLDINGS, Inc.
|
||
Dated: July
29, 2010
|
By:
|
/s/
Peter H. Nielsen
|
Peter
H. Nielsen
|
||
President
and Chief Executive
Officer
|
EXHIBIT
INDEX